[Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting]. / Das kleine hepatozelluläre Karzinom : Leitliniengerechte und klinisch etablierte Diagnostik.
Radiologe
; 62(3): 239-246, 2022 Mar.
Article
en De
| MEDLINE
| ID: mdl-35037980
ABSTRACT
CLINICAL/METHODICAL ISSUE The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2â¯cm-continues to be a radiological challenge. STANDARD RADIOLOGICAL METHODS:
In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard. METHODOLOGICAL INNOVATIONS HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings. PERFORMANCE Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions. ACHIEVEMENTS Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC. PRACTICALRECOMMENDATIONS:
A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Carcinoma Hepatocelular
/
Neoplasias Hepáticas
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Observational_studies
Límite:
Humans
Idioma:
De
Revista:
Radiologe
Año:
2022
Tipo del documento:
Article